cyclotides - CISMeF

Preferred Label : cyclotides;

MeSH definition : A continuous circle of peptide bonds, typically of 2-3 dozen AMINO ACIDS, so there is no free N- or C-terminus. They are further characterized by six conserved CYSTEINE residues that form CYSTINE KNOT MOTIFS.;

MeSH synonym : Cyclotide;

Is substance : O;

Détails

Origin ID

D047169;

UMLS CUI

C1449677;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- cyclotides [MeSH concept]
Related MeSH Supplementary Concept(s)
- MCoTI-I protein, momordica cochinchinensis [MeSH Supplementary Concept]
- MCoTI-III protein, momordica cochinchinensis [MeSH Supplementary Concept]
- PMP-C peptide, insect [MeSH Supplementary Concept]
- PMP-D2 peptide, insect [MeSH Supplementary Concept]
- VHL-1 protein, viola hederaceae [MeSH Supplementary Concept]
- circulin [MeSH Supplementary Concept]
- circulin A [MeSH Supplementary Concept]
- circulin B [MeSH Supplementary Concept]
- cyclopsychotride A [MeSH Supplementary Concept]
- cycloviolacin H4 [MeSH Supplementary Concept]
- cycloviolacin O13 [MeSH Supplementary Concept]
- cycloviolacin O14 [MeSH Supplementary Concept]
- cycloviolacin O2 [MeSH Supplementary Concept]
- cycloviolacin O24 [MeSH Supplementary Concept]
- cycloviolacin T1 [MeSH Supplementary Concept]
- cycloviolacin VY1 [MeSH Supplementary Concept]
- cycloviolacin Y4 [MeSH Supplementary Concept]
- cycloviolacin Y5 [MeSH Supplementary Concept]
- gere 1 cyclotide [MeSH Supplementary Concept]
- hedyotide B1 [MeSH Supplementary Concept]
- hyen D [MeSH Supplementary Concept]
- kalata B1 [MeSH Supplementary Concept]
- kalata B2 [MeSH Supplementary Concept]
- kalata B5, oldenlandia affinis [MeSH Supplementary Concept]
- kalata B6 [MeSH Supplementary Concept]
- kalata B7, oldenlandia affinis [MeSH Supplementary Concept]
- palicourein [MeSH Supplementary Concept]
- psyle A [MeSH Supplementary Concept]
- psyle C [MeSH Supplementary Concept]
- psyle E [MeSH Supplementary Concept]
- trypsin inhibitor MCoTI-II [MeSH Supplementary Concept]
- vaby D [MeSH Supplementary Concept]
- varv A [MeSH Supplementary Concept]
- varv F [MeSH Supplementary Concept]
- vigno 5 cyclotide, Viola ignobilis [MeSH Supplementary Concept]
- violacin A [MeSH Supplementary Concept]
- vodo I1 [MeSH Supplementary Concept]
- vodo I2 [MeSH Supplementary Concept]
- vodo I3 [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients